Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Terminated 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Pemetrexed 2trilaciclib 1trastuzumab deruxtecan 1pembrolizumab 1olaparib 1lorlatinib 1durvalumab 1aumolertinib 1apatinib 1Standard of Care 1Saline Solution 1Radiosurgery 1Patient Navigation 1Observation 1Interviews as Topic 1Gemcitabine 1Drug Delivery Systems 1Cisplatin 1Carboplatin 1Biopsy, Fine-Needle 1Anterior Temporal Lobectomy 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Drug Delivery Systems × Thoracic × Clear all
NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Enrolling by invitation
251 enrolled
Thoracic

Early-stage Peripheral Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡